CLASS II ONGOING Device recall · Reported 18 Dec 2019 · FDA Enforcement Report

Empowr Locking Femoral Impactor , Part # recalled by Encore Medical

Encore Medical is recalling Empowr Locking Femoral Impactor , Part # 800-05-035, distributed in 30 states. The recall was initiated on 4 Feb 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lots
Quantity recalled410 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0611-2020
FDA event ID
84151
Recalling firm
Encore Medical, Austin, TX
Classification
Class II
Status
Ongoing
Recall initiated
4 Feb 2019
FDA classified
6 Dec 2019
Reported
18 Dec 2019
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

4 Feb 2019Recall initiated by company
6 Dec 2019Classified by FDA+305 days
18 Dec 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm has received reports/complaints concerning the breakage of the tips of the locking femoral Impactor. Additionally, if the impactor is not seated correctly on the implant prior to impaction, this may cause off axis loading which can increase the risk of device failure. This could cause a delay in surgery. If the tip is not seen during surgery, long term risks may include an inflammatory response, infection, and/ or pain

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

EMPOWR Locking Femoral Impactor , Part # 800-05-035, packaged in instrument tray FA EMP PAT TOOL KIT Part # 800-99-096

Where it was distributed

CO, WA, CA, UT, CA, TN, TX, MS, MO, AR, OK, LA, MN, IL, IN, KY, OH, MI, PA, SC, FL, PR, AL, GA, NM, AZ, NV, VA, RI, MD, ME PA, NY OUS: None

AlabamaArkansasArizonaCaliforniaColoradoFloridaGeorgiaIllinoisIndianaKentuckyLouisianaMarylandMichiganMinnesotaMissouriMississippiNew MexicoNevadaNew YorkOhio

Questions about this recall

Why was it recalled?

The firm has received reports/complaints concerning the breakage of the tips of the locking femoral Impactor. Additionally, if the impactor is not seated correctly on the implant prior to impaction, this may cause off axis loading which can increase the risk of device failure. This could cause a delay in surgery. If the tip is not seen during surgery, long term risks may include an inflammatory response, infection, and/ or pain

Which lots are affected?

All Lots

Where was it sold?

CO, WA, CA, UT, CA, TN, TX, MS, MO, AR, OK, LA, MN, IL, IN, KY, OH, MI, PA, SC, FL, PR, AL, GA, NM, AZ, NV, VA, RI, MD, ME PA, NY OUS: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Encore Medical

All 99

Other Hip & Knee Implants recalls

All 3,097